Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Replenine-VF in Haemophilia B Surgery
NCT02250560Phase 3Completed
- Sponsor
- Bio Products Laboratory
- Start
- Apr 2000
- Primary completion
- Nov 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of coagulation factor IX human in hemophilia B (HB), sponsored by Bio Products Laboratory. Primary endpoint: Assessment of control of prevention of bleeding. Started Apr 2000; status: completed.
02
Drugs
coagulation factor IX human
03
Conditions
hemophilia B (HB)
Beyond the preview
Go deeper on NCT02250560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02250560.